HROW Stock Analysis: Why Harrow Health Inc Scored 0% in Stock Value Finder

Understanding Harrow Health Inc (HROW): A Detailed StockValueFinder Review

Overview of Harrow Health Inc (HROW)

Harrow Health Inc (HROW) is a healthcare company operating in the specialty and generic drug manufacturing industry. This StockValueFinder review examines the company's financial metrics using a disciplined, number-driven approach. Our goal is to help investors understand how to evaluate stocks systematically rather than to make specific investment recommendations.

At the time of this analysis, HROW trades at $28.44 per share. The company has received a StockValueFinder score of 0% and an "AVOID" rating based on the supplied financial metrics. This educational review will explain each key metric, what ranges are considered strong or weak, and why HROW failed to meet the screening criteria.

Why the StockValueFinder Score Matters

The StockValueFinder score is a composite measure that evaluates multiple financial dimensions of a company. A score of 0% indicates that HROW did not pass any of the core financial tests used in this screening system. While no single metric should determine an investment decision, this score suggests that the company currently exhibits several financial characteristics that may be considered less attractive by value-oriented investors.

It's important to understand that this score reflects a snapshot in time based on available data. Companies can improve their financial position over time, and investors should always conduct their own due diligence before making any investment decisions.

EPS Strength and Consistency

Earnings Per Share (EPS) consistency is a fundamental measure of a company's financial health. EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Consistent and growing EPS over time can indicate a stable and potentially growing business.

**StockValueFinder generally looks for:** – Positive EPS in recent quarters – Consistent or growing EPS over multiple years – No significant negative surprises in earnings reports

**What ranges are considered attractive:** – Positive EPS in the most recent quarter – Year-over-year EPS growth – No more than one negative EPS quarter in the past three years

**What ranges are considered weak:** – Negative EPS in recent quarters – Inconsistent or declining EPS trends – Multiple negative EPS quarters in recent years

**HROW's EPS test result:** Did not pass

The system recorded that HROW did not pass the EPS strength test. While exact EPS values were not supplied for this analysis, the failure to pass this test suggests that the company may have exhibited inconsistent earnings performance or negative EPS in recent periods.

**Educational example:**

Consider two hypothetical companies

– Company A: $1.20 EPS (current quarter), $1.15 EPS (same quarter last year), $1.10 EPS (two years ago) – Company B: -$0.30 EPS (current quarter), $0.10 EPS (same quarter last year), -$0.20 EPS (two years ago)

Company A demonstrates consistent, positive EPS growth, while Company B shows volatility and negative earnings. Most value-oriented screening systems would prefer Company A's EPS profile.

ROIC and Capital Efficiency

Return on Invested Capital (ROIC) measures how effectively a company uses its capital to generate returns. It's calculated by dividing net operating profit after taxes by the company's invested capital.

**HROW's ROIC:** -1.69%

**StockValueFinder generally prefers:** – ROIC of 10% or higher – Consistently positive ROIC over multiple years – ROIC that exceeds the company's cost of capital

**What ranges are considered attractive:** – ROIC above 15%: Excellent capital efficiency – ROIC between 10-15%: Good capital efficiency – ROIC above the company's weighted average cost of capital (WACC)

**What ranges are considered weak:** – ROIC below 5%: Poor capital efficiency – Negative ROIC: The company is destroying value – ROIC below the company's WACC

**Why HROW failed this test:** With an ROIC of -1.69%, HROW is currently generating negative returns on its invested capital. This means the company is not earning enough from its operations to cover its cost of capital, which is generally considered a red flag for value-oriented investors.

**Educational example:**

Imagine two companies with $100 million in invested capital

– Company X generates $15 million in net operating profit after taxes: ROIC = 15% – Company Y generates $4 million in net operating profit after taxes: ROIC = 4%

Company X is using its capital more efficiently, generating higher returns for each dollar invested. Most screening systems would prefer Company X's ROIC profile.

Interest Coverage and Financial Safety

Interest coverage measures a company's ability to pay interest on its outstanding debt. It's calculated by dividing earnings before interest and taxes (EBIT) by interest expenses.

**StockValueFinder generally prefers:** – Interest coverage of 6 or higher – Consistently strong interest coverage over multiple years

**What ranges are considered attractive:** – Interest coverage above 8: Strong ability to service debt – Interest coverage between 6-8: Adequate ability to service debt

**What ranges are considered weak:** – Interest coverage below 3: High risk of default – Interest coverage below 1: Company cannot cover interest payments from earnings

**HROW's interest coverage test result:** Did not pass

While the exact interest coverage ratio was not supplied, the failure to pass this test suggests that HROW's ability to cover its interest expenses with operating earnings may be weak. This could indicate higher financial risk, especially in rising interest rate environments.

**Educational example:**

Consider two companies

– Company P: EBIT of $80 million, interest expenses of $10 million → Interest coverage = 8 – Company Q: EBIT of $20 million, interest expenses of $10 million → Interest coverage = 2

Company P can cover its interest expenses 8 times over with its operating earnings, while Company Q can only cover them twice. Most screening systems would view Company P as having a stronger financial position.

Debt Payback and Balance Sheet Discipline

Debt payback years measures how long it would take a company to pay off all its debt using its current operating cash flow. It's calculated by dividing total debt by annual operating cash flow.

**HROW's debt payback years:** 5.69

**StockValueFinder generally prefers:** – Debt payback of 3 years or less – Consistently improving debt payback metrics

**What ranges are considered attractive:** – Debt payback under 2 years: Strong balance sheet – Debt payback between 2-3 years: Good balance sheet

**What ranges are considered weak:** – Debt payback between 4-7 years: Elevated financial risk – Debt payback over 7 years: High financial risk

**Why HROW failed this test:** With a debt payback period of 5.69 years, HROW would take nearly six years to pay off its debt using its current operating cash flow. This is significantly longer than the preferred threshold of 3 years or less, indicating higher financial leverage and potential balance sheet risk.

**Educational example:**

Imagine two companies with $100 million in debt

– Company R: $50 million in annual operating cash flow → Debt payback = 2 years – Company S: $20 million in annual operating cash flow → Debt payback = 5 years

Company R could pay off its debt in just two years, while Company S would take five years. Most screening systems would view Company R as having better balance sheet discipline.

P/E Ratio and Valuation Discipline

The Price-to-Earnings (P/E) ratio measures a company's current share price relative to its earnings per share. It's a common valuation metric that helps investors assess whether a stock is potentially overvalued or undervalued.

**HROW's P/E ratio:** 62.16

**StockValueFinder generally prefers:** – P/E ratio of 15 or lower for value-oriented screening – P/E ratio that is reasonable relative to the company's growth rate – P/E ratio that is attractive compared to industry peers

**What ranges are considered attractive:** – P/E below 10: Potentially undervalued (if business quality is sound) – P/E between 10-15: Reasonable valuation

**What ranges are considered weak:** – P/E between 20-30: Potentially overvalued – P/E above 30: High valuation, may require exceptional growth to justify – P/E above 50: Very high valuation, typically requires extraordinary growth prospects

**Why HROW failed this test:** With a P/E ratio of 62.16, HROW is trading at a very high multiple of its earnings. This suggests that investors are paying $62.16 for every $1 of the company's current earnings. Such a high valuation typically requires exceptional growth prospects to be considered reasonable.

**Educational example:**

Consider two companies in the same industry

– Company T: $50 share price, $5 EPS → P/E = 10 – Company U: $50 share price, $1 EPS → P/E = 50

Company T is trading at 10 times earnings, while Company U is trading at 50 times earnings. Assuming similar growth prospects, most value-oriented investors would view Company T as more attractively valued.

Moving Average Trend and Entry Timing

Moving averages are technical indicators that smooth out price data to help identify trends. While StockValueFinder primarily focuses on fundamental analysis, it also considers trend indicators for timing discipline.

**HROW's moving average signal:** SELL / AVOID TREND **Entry signal:** N/A

**StockValueFinder's approach to moving averages:** – Used for timing discipline, not as a primary investment signal – Helps identify potential entry and exit points – Not a guarantee of future performance

**What different signals typically mean:** – BUY / UPTREND: Price is above key moving averages, suggesting potential upward momentum – SELL / AVOID TREND: Price is below key moving averages, suggesting potential downward momentum – NEUTRAL: Price is near moving averages, suggesting indecision

**HROW's current trend:** The SELL / AVOID TREND signal indicates that HROW's price is currently below key moving averages. This suggests that the stock may be in a downtrend or showing weaker momentum compared to its historical price action.

**Educational example:**

Imagine two stocks

– Stock V: Price is consistently above its 50-day and 200-day moving averages – Stock W: Price is consistently below its 50-day and 200-day moving averages

Most trend-following systems would view Stock V as being in a stronger technical position than Stock W.

Overall Financial Strengths and Weaknesses

Based on the supplied metrics, HROW exhibits several financial characteristics that may be considered less attractive by value-oriented investors:

**Strengths:** – The analysis did not identify any specific strengths based on the supplied metrics.

**Weaknesses:** 1. **Negative ROIC (-1.69%):** The company is currently generating negative returns on its invested capital, indicating poor capital efficiency. 2. **High P/E ratio (62.16):** The stock is trading at a very high multiple of earnings, suggesting a high valuation that may require exceptional growth to justify. 3. **Long debt payback period (5.69 years):** The company would take nearly six years to pay off its debt using current operating cash flow, indicating higher financial leverage. 4. **Failed interest coverage test:** The company's ability to cover interest expenses with operating earnings appears weak. 5. **Failed EPS test:** The company has not demonstrated consistent or positive earnings performance. 6. **SELL / AVOID TREND:** The stock is showing weaker technical momentum.

Risks and Limitations

It's important to understand the limitations of this analysis

1. **Snapshot in time:** The metrics represent a single point in time and may change as the company's financial position evolves. 2. **Limited data:** This analysis is based on the supplied metrics only. Additional financial data, industry context, or qualitative factors could provide a more complete picture. 3. **No future predictions:** This analysis does not predict future performance or guarantee any specific outcomes. 4. **Sector considerations:** Different industries have different financial norms. What might be considered weak in one sector could be normal in another. 5. **Growth vs. value:** Some investors may be willing to accept higher valuations or weaker balance sheets for companies with strong growth prospects. 6. **Macroeconomic factors:** Interest rates, regulatory changes, and other external factors can significantly impact a company's financial position.

Educational Conclusion

This StockValueFinder review of Harrow Health Inc (HROW) provides a disciplined, number-driven approach to evaluating stocks. The company received a 0% score and an "AVOID" rating based on the supplied financial metrics, failing all core tests including EPS strength, ROIC, interest coverage, debt payback, and P/E valuation.

Key takeaways for investors learning to evaluate stocks

1. **EPS consistency matters:** Look for companies with positive and growing earnings over time. 2. **ROIC reveals capital efficiency:** Companies with ROIC above 10% are generally using capital more effectively. 3. **Interest coverage indicates financial safety:** Higher interest coverage ratios suggest stronger ability to service debt. 4. **Debt payback shows balance sheet discipline:** Shorter debt payback periods generally indicate stronger financial positions. 5. **P/E ratio helps assess valuation:** Lower P/E ratios may indicate more attractive valuations, assuming business quality is sound. 6. **Trend indicators provide timing discipline:** Moving averages can help identify potential entry and exit points.

Remember that no single metric should determine an investment decision. Always consider multiple financial dimensions, conduct thorough due diligence, and understand your own investment objectives and risk tolerance.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.

---

Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings